Short testimonial videos to encourage diabetic eye screening in Latinx communities

Development of a Culturally Adapted, Video-based Patient Education Intervention to Increase Diabetic Eye Screening and Teleophthalmology Use in Latinx Communities

Not applicable Interventional University of Wisconsin, Madison · NCT06257082

This project will test whether short Spanish-language testimonial videos from Latinx patients, Latinx clinicians, or both can increase eye health knowledge, trust, and willingness to use teleophthalmology among Latinx adults with diabetes.

Quick facts

PhaseNot applicable
Study typeInterventional
Enrollment1526 (estimated)
Ages18 Years and up
SexAll
SponsorUniversity of Wisconsin, Madison Academic / other
Locations1 site (Madison, Wisconsin)
Trial IDNCT06257082 on ClinicalTrials.gov

What this trial studies

Investigators will record brief video testimonials from three Latinx patients with diabetes and three Latinx clinicians, conducted in Spanish with English subtitles, using prompts to elicit key culturally relevant messages. A bilingual community outreach specialist will lead four stakeholder meetings to adapt these testimonials into culturally tailored patient-education videos. An online randomized survey of 1,500 self-identified Hispanic/Latino adults will then compare three video conditions (patient+clinician, patient-only, clinician-only) against two controls (a standard National Eye Institute video and a questionnaire-only control) using pre- and post-measures in a mixed-effects design. Outcomes include changes in eye health literacy, trust in care, and intentions to use teleophthalmology for diabetic eye screening.

Who should consider this trial

Good fit: Ideal participants are Latinx adults with diabetes—survey participants simply need to self-identify as Hispanic/Latino, while those who record testimonials or attend stakeholder meetings should be Latinx patients or clinicians affiliated with Access Community Health Centers or UW Health in Madison, WI.

Not a fit: Patients who are not Latinx, who already receive regular diabetic eye screening, or who lack internet access to view online videos are unlikely to benefit from this intervention.

Why it matters

Potential benefit: If successful, the videos could increase screening uptake and earlier detection of diabetic retinopathy by improving understanding and trust in teleophthalmology among Latinx patients.

How similar studies have performed: Teleophthalmology programs and culturally tailored educational videos have improved screening rates in prior work, though combining patient-plus-clinician testimonial videos specifically for Latinx communities is a relatively novel approach.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria (online survey participants):

* Self-Identifies as Hispanic or Latino

Inclusion Criteria (patient video testimonials):

* Self-Identifies as Hispanic or Latino
* diagnosed with diabetes
* treated at Access Community Health Centers and UW Health in Madison, WI

Inclusion Criteria (clinician video testimonials):

* Self-Identifies as Hispanic or Latino
* clinician who treats patients with diabetes at Access Community Health Centers and UW Health in Madison, WI

Inclusion Criteria (focus group participants):

* Self-Identifies as Hispanic or Latino
* diagnosed with type 1 or type 2 diabetes

Exclusion Criteria:

\-

Where this trial is running

Madison, Wisconsin

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions Diabetic Retinopathyteleophthalmology
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.